Opal Capital’s Medtronic MDT Stock Holding History

Opal Capital’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,135	Closed	-$319K	–	190
2025 Q4	$319K	Buy	+3,135	New	+$305K	0.08%	128

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Opal Capital's MDT Position: Q1 2026 in Review

Opal Capital sold out of Medtronic (MDT) in Q1 2026, closing a stake of 3,135 shares — an estimated $319K sold.

Opal Capital first reported a position in MDT in Q4 2025 and held it in 1 quarter. The position peaked at $319K in Q4 2025. 2,244 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Opal Capital reported no remaining Medtronic position as of Q1 2026 after selling out during the quarter.
Opal Capital sold 3,135 Medtronic shares in Q1 2026, an estimated $319K.
Opal Capital first reported a position in Medtronic in Q4 2025 and held it in 1 quarter.
Opal Capital's Medtronic position peaked at $319K in Q4 2025.
2,244 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Opal Capital's 13F filing for Q1 2026, filed 18 May 2026.